Literature DB >> 24157494

Oral misoprostol versus vaginal dinoprostone for labor induction in nulliparous women at term.

A M Faucett1, K Daniels1, H C Lee2, Y Y El-Sayed1, Y J Blumenfeld1.   

Abstract

OBJECTIVE: To compare the efficacy of oral misoprostol to vaginal dinoprostone for labor induction in nulliparous women. STUDY
DESIGN: Admissions for labor induction from January 2008 to December 2010 were reviewed. Patients receiving oral misoprostol were compared with those receiving vaginal dinoprostone. The primary outcome was time from induction agent administration to vaginal delivery. Secondary outcomes included vaginal delivery within 24 h, mode of delivery and maternal and fetal outcomes. RESULT: A total of 680 women were included: 483 (71%) received vaginal dinoprostone and 197 (29%) received oral misoprostol. Women who received oral misoprostol had a shorter interval to vaginal delivery (27.2 vs 21.9 h, P<0.0001) and were more likely to deliver vaginally in <24 h (47% vs 64%, P=0.001). There was no increase in the rate of cesarean delivery or adverse maternal or neonatal outcomes.
CONCLUSION: Labor induction with oral misoprostol resulted in shorter time to vaginal delivery without increased adverse outcomes in nulliparous women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24157494     DOI: 10.1038/jp.2013.133

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  23 in total

Review 1.  Vaginal misoprostol for cervical ripening and induction of labour.

Authors:  G Justus Hofmeyr; A Metin Gülmezoglu; Cynthia Pileggi
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  Oral misoprostol for induction of labour.

Authors:  Z Alfirevic; A Weeks
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

3.  Oral misoprostol versus intracervical dinoprostone for induction of labor.

Authors:  E J Langenegger; H J Odendaal; D Grové
Journal:  Int J Gynaecol Obstet       Date:  2005-01-16       Impact factor: 3.561

4.  ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-07       Impact factor: 7.661

5.  Oral misoprostol for induction of labour at term: randomised controlled trial.

Authors:  Jodie M Dodd; Caroline A Crowther; Jeffrey S Robinson
Journal:  BMJ       Date:  2006-02-02

6.  Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol.

Authors:  Iris Colón; Kaytha Clawson; Kennith Hunter; Maurice L Druzin; M Mark Taslimi
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

7.  A randomised comparison of oral misoprostol and vaginal prostaglandin E2 tablets in labour induction at term.

Authors:  A Shetty; I Livingstone; S Acharya; P Rice; P Danielian; A Templeton
Journal:  BJOG       Date:  2004-05       Impact factor: 6.531

8.  Misoprostol for induction of labor with a live fetus.

Authors:  A Weeks; Z Alfirevic; A Faúndes; G J Hofmeyr; P Safar; D Wing
Journal:  Int J Gynaecol Obstet       Date:  2007-10-25       Impact factor: 3.561

9.  Low-dose oral misoprostol for induction of labor: a systematic review.

Authors:  Timothy W Kundodyiwa; Zarko Alfirevic; Andrew D Weeks
Journal:  Obstet Gynecol       Date:  2009-02       Impact factor: 7.661

10.  Impact of labor induction, gestational age, and maternal age on cesarean delivery rates.

Authors:  Linda J Heffner; Elena Elkin; Ruth C Fretts
Journal:  Obstet Gynecol       Date:  2003-08       Impact factor: 7.661

View more
  2 in total

1.  Sublingual Misoprostol (PGE1) Versus Intracervical Dinoprostone (PGE2) Gel for Induction of Labour: A Randomized Control Trail.

Authors:  Braganza Veena; Rajinish Samal; Leeberk R Inbaraj; Carolin Elizabeth George
Journal:  J Obstet Gynaecol India       Date:  2015-12-29

2.  Comparative study of titrated oral misoprostol solution and vaginal dinoprostone for labor induction at term pregnancy.

Authors:  Xiu Wang; Aijun Yang; Qingyong Ma; Xuelan Li; Li Qin; Tongqiang He
Journal:  Arch Gynecol Obstet       Date:  2016-01-08       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.